| Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis TLA Nguyên, H Abdelbary, M Arguello, C Breitbach, S Leveille, JS Diallo, ... Proceedings of the National Academy of Sciences 105 (39), 14981-14986, 2008 | 222 | 2008 |
| Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins A Yasmeen, MC Beauchamp, E Piura, E Segal, M Pollak, WH Gotlieb Gynecologic oncology 121 (3), 492-498, 2011 | 170 | 2011 |
| Induction, production, repression, and de-repression of exoglucanase synthesis in Aspergillus niger A Hanif, A Yasmeen, MI Rajoka Bioresource Technology 94 (3), 311-319, 2004 | 170 | 2004 |
| High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: a tissue microarray study N Akil, A Yasmeen, A Kassab, L Ghabreau, AD Darnel, AE Al Moustafa British journal of cancer 99 (3), 404-407, 2008 | 152 | 2008 |
| E-and A-type cyclins as markers for cancer diagnosis and prognosis A Yasmeen, WE Berdel, H Serve, C Müller-Tidow Expert review of molecular diagnostics 3 (5), 617-633, 2003 | 139 | 2003 |
| E6/E7 of HPV type 16 promotes cell invasion and metastasis of human breast cancer cells A Yasmeen, TA Bismar, M Kandouz, WD Foulkes, PY Desprez, ... Cell cycle 6 (16), 2038-2042, 2007 | 127 | 2007 |
| EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas AE Al Moustafa, A Achkhar, A Yasmeen Front Biosci (Schol Ed) 4 (2), 671-84, 2012 | 116 | 2012 |
| Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer I Laskov, L Drudi, MC Beauchamp, A Yasmeen, A Ferenczy, M Pollak, ... Gynecologic oncology 134 (3), 607-614, 2014 | 112 | 2014 |
| Relevance of the OCT1 transporter to the antineoplastic effect of biguanides ED Segal, A Yasmeen, MC Beauchamp, J Rosenblatt, M Pollak, ... Biochemical and biophysical research communications 414 (4), 694-699, 2011 | 112 | 2011 |
| Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors CA Philip, I Laskov, MC Beauchamp, M Marques, O Amin, J Bitharas, ... BMC cancer 17, 1-11, 2017 | 109 | 2017 |
| Targeting insulin and insulin‐like growth factor pathways in epithelial ovarian cancer MC Beauchamp, A Yasmeen, A Knafo, WH Gotlieb Journal of oncology 2010 (1), 257058, 2010 | 102 | 2010 |
| Teucrium polium plant extract inhibits cell invasion and motility of human prostate cancer cells via the restoration of the E-cadherin/catenin complex M Kandouz, A Alachkar, L Zhang, H Dekhil, F Chehna, A Yasmeen, ... Journal of ethnopharmacology 129 (3), 410-415, 2010 | 88 | 2010 |
| Co-prevalence of Epstein–Barr virus and high-risk human papillomaviruses in Syrian women with breast cancer AE Al Moustafa, N Al-Antary, T Aboulkassim, N Akil, G Batist, A Yasmeen Human vaccines & immunotherapeutics 12 (7), 1936-1939, 2016 | 66 | 2016 |
| Human papillomaviruses-related cancers: Presence and prevention strategies in the Middle East and North African Regions AE Al Moustafa, R Al-Awadhi, N Missaoui, I Adam, R Durusoy, ... Human vaccines & immunotherapeutics 10 (7), 1812-1821, 2014 | 58 | 2014 |
| Locking Src/Abl tyrosine kinase activities regulate cell differentiation and invasion of human cervical cancer cells expressing E6/E7 oncoproteins of high‐risk HPV A Yasmeen, A Alachkar, H Dekhil, C Gambacorti-Passerini, ... Journal of oncology 2010 (1), 530130, 2010 | 54 | 2010 |
| Identification of deregulated genes by single wall carbon-nanotubes in human normal bronchial epithelial cells A Alazzam, E Mfoumou, I Stiharu, A Kassab, A Darnel, A Yasmeen, ... Nanomedicine: Nanotechnology, Biology and Medicine 6 (4), 563-569, 2010 | 53 | 2010 |
| Induction, and production studies of a novel glucoamylase of Aspergillus niger MI Rajoka, A Yasmeen World Journal of Microbiology and Biotechnology 21, 179-187, 2005 | 52 | 2005 |
| High-risk HPV/ErbB-2 interaction on E-cadherin/catenin regulation in human carcinogenesis AE Al Moustafa, A Kassab, A Darnel, A Yasmeen Current pharmaceutical design 14 (22), 2159-2172, 2008 | 51 | 2008 |
| ErbB receptors and epithelial-cadherin–catenin complex in human carcinomas A Yasmeen, TA Bismar, AE Al Moustafa Future Oncology 2 (6), 765-781, 2006 | 50 | 2006 |
| Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer R Kessous, I Laskov, J Abitbol, J Bitharas, A Yasmeen, S Salvador, S Lau, ... Gynecologic oncology 144 (3), 474-479, 2017 | 49 | 2017 |
